Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Combination Statin, Acetylsalicylic Acid and Dutasteride Use on Prostate Cancer - a Sub Analysis of the REDUCE Trial

NCT01428869 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT01428869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01428869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Combination Statin, Acetylsalicylic Acid and Dutasteride Use on Prostate Cancer - a Sub Analysis of the REDUCE Trial
Lead sponsor
University Health Network, Toronto
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
August 31, 2011
Enrollment
8,231 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer